Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial*
- 1 April 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 48 (4) , 535-541
- https://doi.org/10.1067/mjd.2003.143
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Chronic urticariaJournal of Allergy and Clinical Immunology, 2000
- The pathogenesis of chronic idiopathic urticaria.Archives of Dermatology, 1997
- Chronic UrticariaNew England Journal of Medicine, 1995
- Adhesion molecule expression and the inflammatory cell infiltrate in delayed pressure urticariaBritish Journal of Dermatology, 1994
- Autoantibodies against the High-Affinity IgE Receptor as a Cause of Histamine Release in Chronic UrticariaNew England Journal of Medicine, 1993
- Detection of circulating histamine releasing autoantibodies with functional properties of anti‐IgE in chronic urticariaClinical and Experimental Allergy, 1991
- Skin responses to intradermal histamine and leukotrienes C4, D4, and E4 in patients with chronic idiopathic urticaria and in normal subjectsJournal of Allergy and Clinical Immunology, 1990
- The Pathology of the Autologous Serum Skin Test Response in Chronic Urticaria Resembles IgE-Mediated Late-Phase ReactionsInternational Archives of Allergy and Immunology, 1990
- Urticaria: then and nowBritish Journal of Dermatology, 1988
- Assessment of tissue fluid histamine levels in patients with urticariaJournal of Allergy and Clinical Immunology, 1978